Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.82 USD | +0.28% | +0.43% | +18.93% |
17/05 | UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating | MT |
15/05 | Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.93% | 316.16Cr | |
+12.50% | 176.45Cr | |
+14.18% | 156.89Cr | |
-11.54% | 121.23Cr | |
+22.48% | 79Cr | |
+6.72% | 65Cr | |
+40.10% | 60Cr | |
+43.94% | 53Cr | |
-4.17% | 51Cr | |
+103.82% | 37Cr |
- Stock Market
- Equities
- HTGC Stock
- News Hercules Capital, Inc.
- UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating